Effect of a High‐Fat Meal on the Pharmacokinetics of the HIV Integrase Inhibitor Cabotegravir

Cabotegravir is an integrase inhibitor in clinical development for the treatment and prevention of HIV infection using oral tablets for short‐term, lead‐in use before subsequent administration of a long‐acting injectable formulation. This phase 1, single‐center, randomized, 2 × 2 crossover study eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Parul, Ford, Susan L., Lou, Yu, Bakshi, Kalpana, Tenorio, Allan R., Zhang, Zhiping, Pan, Rennan, Spreen, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585996/
https://www.ncbi.nlm.nih.gov/pubmed/30230694
http://dx.doi.org/10.1002/cpdd.620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585996/
https://www.ncbi.nlm.nih.gov/pubmed/30230694
http://dx.doi.org/10.1002/cpdd.620

Ejemplares similares